Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bauman

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Nature Chemical Biology|September 28, 2011
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffoldsTina R White, Chad M Renzelman, Arthur C Rand, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolism-guided design of short-acting calcium-sensing receptor antagonistsJames A Southers, Jonathan N Bauman, David A Price, et al.
Clinical Pharmacology and Therapeutics|March 20, 2026
Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging TrendsJason Boer, Ellen Cannady, Filip Cuyckens, et al.
Chemical Research in Toxicology|May 29, 2010
Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosisAmit S Kalgutkar, David A Griffith, Tim Ryder, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formationDaniel P Walker, F Christopher Bi, Amit S Kalgutkar, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Nature Chemical Biology|September 28, 2011
On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffoldsTina R White, Chad M Renzelman, Arthur C Rand, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Metabolism-guided design of short-acting calcium-sensing receptor antagonistsJames A Southers, Jonathan N Bauman, David A Price, et al.
Clinical Pharmacology and Therapeutics|March 20, 2026
Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging TrendsJason Boer, Ellen Cannady, Filip Cuyckens, et al.
Chemical Research in Toxicology|May 29, 2010
Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosisAmit S Kalgutkar, David A Griffith, Tim Ryder, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formationDaniel P Walker, F Christopher Bi, Amit S Kalgutkar, et al.
Pageof 6